News for 'Ranbaxy Laboratories'

Mid-cap pharma stocks look good

Sensex ends flat amid choppy trade; Nifty above 7,500

BSE Midcap and Smallcap indices ended in line with their larger counterparts and closed marginally up 0.2% and 0.4%, each

Matrix bags US FDA nod for fluconazole

Pharma power

'US FDA not on a witch hunt against India pharma firms'

This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy

216 stocks scale all-time highs since Nov 1

Markets snap 2-day losing streak; Nifty ends above 8,400

Shares of ING Vysya Bank and Kotak Mahindra Bank rallied by up to 6% on the BSE on reports that Kotak Mahindra Bank in final stages to buy the bank.

Sensex ends flat after hitting life-time high of 28,283

Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.

Sensex ends in the red amid volatile trade; IT, auto, realty fall

The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,543.

Fortis' Shivinder Singh to step down; to join spiritual organisation

Fortis Healthcare Executive Vice-Chairman Shivinder Mohan Singh is stepping down from his position to join a philosophical and spiritual organisation.

FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.

3 Indian pharma firms named in US Congress price probe

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.

No FSSAI role in product nod raises eyebrows

Experts believe market launches can now happen seamlessly and quickly if FSSAI is removed from the process.

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

Sensex marks lowest close in 10 weeks; power trips, IT, auto up

The 30-share Sensex ended 50 points lower at 28,112 and the 50-share Nifty declined 12 points to close at 8,531.

Weak China, India PMI data drag markets sixth straight day

Top losers are Sun Pharma, Bajaj Auto, L&T, ITC, Hero Moto.

Twenty-five essential drugs to see 90% decline in prices

The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines

FDI reforms: Now, pharma in focus

FDI in brownfield investment has resulted in acquisition of domestic drug-manufacturing firms by multinational companies.

Keep us in loop before any FDA swoop, India tells US

Inspections only in domestic authorities' presence, visiting US drug regulator told

Indian drug cos to benefit as US expedites generic clearances

Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.

Markets end flat amid volatility

The Sensex ended below 28,000 for the second straight day at 27,869.

Billionaire Club: India's 100 richest business tycoons

A majority of India's billionaires gained wealth in the last one year in spite of the stock market decline.